These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 6147154)

  • 1. Dose-response relationships and neuromuscular blocking effects of vecuronium pancuronium during ketamine anaesthesia.
    Engbaek J; Ording H; Pedersen T; Viby-Mogensen J
    Br J Anaesth; 1984 Sep; 56(9):953-7. PubMed ID: 6147154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular blocking effects of vecuronium and pancuronium during halothane anaesthesia.
    Engbaek J; Ording H; Viby-Mogensen J
    Br J Anaesth; 1983 Jun; 55(6):497-500. PubMed ID: 6134535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Edrophonium and neostigmine for reversal of the neuromuscular blocking effect of vecuronium.
    Engbaek J; Ording H; Ostergaard D; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1985 Jul; 29(5):544-6. PubMed ID: 2863917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular blocking effects of atracurium, vecuronium and pancuronium during bolus and infusion administration.
    Gramstad L; Lilleaasen P
    Br J Anaesth; 1985 Nov; 57(11):1052-9. PubMed ID: 2864943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atracurium and vecuronium: effect of dose on the time of onset.
    Healy TE; Pugh ND; Kay B; Sivalingam T; Petts HV
    Br J Anaesth; 1986 Jun; 58(6):620-4. PubMed ID: 2871849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical studies on Org NC 45: comparison with pancuronium.
    Kerr WJ; Baird WL
    Br J Anaesth; 1982 Nov; 54(11):1159-65. PubMed ID: 6128012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacology of ORG NC45 (NorcuronTM): a new nondepolarizing muscle relaxant.
    Fahey MR; Morris RB; Miller RD; Sohn YJ; Cronnelly R; Gencarelli P
    Anesthesiology; 1981 Jul; 55(1):6-11. PubMed ID: 6113794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetics and dynamics of vecuronium and pancuronium in anesthetized patients.
    Sohn YJ; Bencini AF; Scaf AH; Kersten UW; Agoston S
    Anesth Analg; 1986 Mar; 65(3):233-9. PubMed ID: 2869721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacodynamics of vecuronium in infants during intravenous induction of anesthesia with ketamine].
    Friesdorf W; Schultz M; Fösel T; Altemeyer KH
    Anaesthesist; 1986 Feb; 35(2):99-102. PubMed ID: 2870662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between pancuronium bromide and vecuronium bromide.
    Rashkovsky OM; Agoston S; Ket JM
    Br J Anaesth; 1985 Nov; 57(11):1063-6. PubMed ID: 2864945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does intravenous infusion of nitroglycerin potentiate pancuronium- and vecuronium-induced neuromuscular blockade?
    Schwarz S; Agoston S; Houwertjes MC
    Anesth Analg; 1986 Feb; 65(2):156-60. PubMed ID: 2867718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromuscular blocking action of vecuronium in the dog and its reversal by neostigmine.
    Jones RS
    Res Vet Sci; 1985 Mar; 38(2):193-6. PubMed ID: 2860709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some effects of diisopropyl phenol (ICI 35 868) on the pharmacodynamics of atracurium and vecuronium in anaesthetized man.
    Robertson EN; Fragen RJ; Booij LH; van Egmond J; Crul JF
    Br J Anaesth; 1983 Aug; 55(8):723-8. PubMed ID: 6136286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate of onset of good intubating conditions, respiratory depression and hand muscle paralysis after vecuronium.
    Bencini A; Newton DE
    Br J Anaesth; 1984 Sep; 56(9):959-65. PubMed ID: 6147155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of org NC 45 (vecuronium) and pancuronium neuromuscular blockade by neostigmine.
    Gencarelli PJ; Miller RD
    Br J Anaesth; 1982 Jan; 54(1):53-6. PubMed ID: 6119998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery times following edrophonium and neostigmine reversal of pancuronium, atracurium, and vecuronium steady-state infusions.
    Kopman AF
    Anesthesiology; 1986 Dec; 65(6):572-8. PubMed ID: 2878631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hepatic uptake of vecuronium bromide and its putative metabolites on their neuromuscular blocking actions in the cat.
    Bencini AF; Houwertjes MC; Agoston S
    Br J Anaesth; 1985 Aug; 57(8):789-95. PubMed ID: 2861840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onset time and duration of action for atracurium, Org NC45 and pancuronium.
    Gramstad L; Lilleaasen P; Minsaas B
    Br J Anaesth; 1982 Aug; 54(8):827-30. PubMed ID: 6125161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cumulative and single bolus dose techniques for determining the potency of vecuronium.
    Gibson FM; Mirakhur RK; Clarke RS; Lavery GG
    Br J Anaesth; 1985 Nov; 57(11):1060-2. PubMed ID: 2864944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between the continuous infusion of vecuronium and the intermittent administration of pancuronium and vecuronium.
    Noeldge G; Hinsken H; Buzello W
    Br J Anaesth; 1984 May; 56(5):473-7. PubMed ID: 6144316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.